4Rasmusson B,Vejborg I,Jensen AB,et al.Irradiation of bone metastases in breast cancer patients:a randomized study with 1 year follows up[J].Radiother Oncol,1995,34(3):179.
5Tyrreu CJ.Role of pamidronate in the management of bone metastases from breast cancer[J].Ann Oncol,1994,5(Supp17):37.
6Kunzmann V.Stimulation of gammadelta T cells by aminobisphos-phonates and induction of antiplasma cell activity in multiple myeloma[J].Blood,2000,96(2):384-392.
7Johnston AD. Pathology of metasttic tumors in bone [ J ].Clin Orthop, 1970,73:8.
8Hilner BE, ingle JN, Chelbowski RT, et al. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer[J] . J Clin Oncol,2003,21 (21) :4042-4057.
9Kouloulias V, Matsopoulos G, Kouvaris J, et al. Radiotherapy in conjunction with intravenous inrfsion of 180 mg of disodium pamidronate in management of osteolytic metastases from beast cancer: clinical evaluation, biochemical markers, quality of life, and monitoring of recaliflcation using assessments of gray - level histogram in plain radiographs [ J ]. Int J Radiat Oncol Biol Phys, 2003,57 ( 1 ) :143 - 157.
